Guilherme Carvalho Inc Hemet, CA - 92543

Guilherme Carvalho Inc is categorized under Internal Medicine Doctors in Hemet, CA and active since 1979.

Guilherme Carvalho Inc was established in 1979, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Chitra Carvalho, Office Manager at the company’s single location by writing to 118 North Santa Fe St # A, Hemet, California CA 92543 or by phoning (951) 652-6891. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Guilherme Carvalho Inc
Contact Person: Chitra Carvalho, Office Manager
Address: 118 North Santa Fe St # A, Hemet, California 92543
Phone Number: (951) 652-6891
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 1979
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Guilherme Carvalho Inc was started in 1979 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Chitra Carvalho, Office Manager for inquiries that concern Guilherme Carvalho Inc by calling the company number (951) 652-6891, as your correspondence is most welcome. Additionally, the physical location of the single location of Guilherme Carvalho Inc can be found at the coordinates 33.747964,-116.962916 as well as the street address 118 North Santa Fe St # A in Hemet, California 92543.

For its online presence, you may visit Guilherme Carvalho Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.